Loading provider…
Loading provider…
Dermatology Physician in Lenexa, KS
NPI: 1275700528Primary Practice Location
Mawd Pathology Group PA
9705 Lenexa Dr, Lenexa, KS
Primary Employer
Derm Hair Center
dermhaircenter.org
HQ Phone
Get MD Meena's Phone NumberMobile
Get MD Meena's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKS State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 17311Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | 273 | 340 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 135 | 182 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 128 | 148 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 125 | 131 |
| 5 | 13132Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | 110 | 123 |
Authors: Marc Avram
Journal: J Clin Aesthet Dermatol
Technical considerations for follicular unit extraction in African-American hair.
Authors: Singh, Meena K, Avram, Marc R
Journal: Dermatol Surg
Publication Date: 2013-05-13
A cytomics-on-a-chip platform and diagnostic model stratifies risk for oral lichenoid conditions.
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Lebrikizumab
Lead Sponsor: Eli Lilly and Company
Collaborators: Dermira, Inc.
Intervention / Treatment: BIOLOGICAL: Lebrikizumab